The Ono Pharmaceutical Group's performance may be significantly affected ...
With the aim of increasing children’s interest in science, experiments, a...
We provide training not only for the members of the department in charge ...
We implement all the principles of the Corporate Governance Code stipulat...
We recognize our responsibility, as a pharmaceutical company involved in ...
Towards “Realization of a water recycling society,” medium- to long-term...
We set targets for sustainability, including environmental and occupation...
Compliance Promotion System To strengthen our compliance system, we ha...
In October 2019, we announced our support for the Task Force on Climate-rel...
Since the misconduct that occurred in FY2020 (hereinafter referred to as ...
In September 2023, ONO joined PSCI (Pharmaceutical Supply Chain In...
At Ono Pharmaceutical, the Board of Directors oversees important manageme...
We organized a resource recycling sub-committee consisting of waste manag...
Please refer to the “Corporate Governance Report” below for details on ou...
Approach to Social Contribution Activities ONO’s Social Contribution A...
We have established an internal system in accordance with the basic views...
Environmental Costs (Including Depreciation Costs) (Thousands o...
In the evaluation on climate change conducted by the CDP, a global e...
In order to resolve natural environmental issues, including climate ch...
Analysis and Evaluation of Risks and Opportunities related to Climate Ch...
